Close
Nordic 9Nordic 9

Merck Ventures (investor - Corporate Investor)

Netherlands m-ventures.com
See something wrong or missing? Let us know
Offices:Amsterdam

Merck Ventures (M ventures) is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany, with a mandate is to invest in innovative technologies and products with the potential to significantly impact Merck's core business areas.

Average round investment:39.26M USD
Average number per year:4.9
Distribution: 2025 (4)2024 (10)2023 (8)2022 (2)2021 (3) See the entire list
Portfolio companies: United Kingdom NRG TherapeuticsNorway ActitheraSwitzerland ReproNovo See the entire list
Mostly invests in: United Kingdom United Kingdom (12) Health services (28)
See the entire list

Showing 3 of 39 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Merck Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Merck Ventures

Name Criteria
United States TQ Ventures
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data), FMCG, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Netherlands, France, Finland
  • Average number of deals per year: 4.2
  • Active last 12 months: Yes
France BlackFin Capital Partners
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Netherlands, France, Denmark, Finland
  • Average number of deals per year: 5.1
  • Active last 12 months: Yes
Switzerland VI Partners AG
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, AI (big data), Hardware, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: Switzerland, Germany, Netherlands, France
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
Belgium SFPIM
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Food Industry, Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: France
  • Average number of deals per year: 5.3
  • Active last 12 months: Yes
United States Felicis Ventures
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Food Industry, AI (big data), Hardware, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Netherlands, France, United States, Finland
  • Average number of deals per year: 3.4
  • Active last 12 months: Yes
United States Citigroup
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, France, Finland
  • Average number of deals per year: 6.5
  • Active last 12 months: Yes
United States JJDC - Johnson & Johnson
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, AI (big data), Hardware, Robotics
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Netherlands, France, Finland
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Germany D11Z Ventures
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Electronics, AI (big data), Hardware, Competitive Intelligence, Robotics
  • Similar business models: B2B, SAAS
  • Common investees countries: Switzerland, Germany, Finland
  • Average number of deals per year: 4.5
  • Active last 12 months: Yes
France Olivier Pomel
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Software Services, AI (big data), Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Netherlands, France, United States, Finland
  • Average number of deals per year: 4.8
  • Active last 12 months: Yes
Germany Acton Capital Partners
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data), Hardware, FMCG, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, France, Finland
  • Average number of deals per year: 4.4
  • Active last 12 months: Yes
Top